Peak antifactor xa activity produced by dalteparin treatment in patients with renal impairment compared with controls.

Abstract:

STUDY OBJECTIVE:To evaluate the relationship between impaired renal function and antifactor Xa activity in patients receiving dalteparin. DESIGN:Open-label prospective study. SETTING:Inpatient and outpatient units of a large teaching hospital. SUBJECTS:Eleven patients with renal impairment and 11 control subjects with normal renal function. INTERVENTION:Subjects were administered dalteparin at a dosage of approximately 100 U/kg subcutaneously every 12 hours. MEASUREMENTS AND MAIN RESULTS:Peak steady-state antifactor Xa levels were compared between the groups. Mean +/- SD levels were similar for patients with and without renal impairment: 0.47 +/- 0.25 and 0.55 +/- 0.20 U/ml, respectively. A test of equivalency showed statistical significance (p=0.0001). CONCLUSION:No meaningful difference in peak antifactor Xa activity was found between patients with renal impairment and control subjects. To the extent that peak antifactor Xa levels can be used as markers for adjusting doses of dalteparin, these data suggest that such adjustments are not necessary for patients with renal impairment who are not receiving dialysis.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Shprecher AR,Cheng-Lai A,Madsen EM,Cohen HW,Sinnett MJ,Wong ST,Billett HH

doi

10.1592/phco.2005.25.6.817

subject

Has Abstract

pub_date

2005-06-01 00:00:00

pages

817-22

issue

6

eissn

0277-0008

issn

1875-9114

journal_volume

25

pub_type

临床试验,杂志文章
  • Analgesic efficacy of meclofenamate sodium in episiotomy pain.

    abstract::Meclofenamate sodium was compared, double-blind, with codeine and placebo for the treatment of acute episiotomy pain. One hundred sixty-eight women with moderate or severe episiotomy pain after normal delivery were assigned randomly to one of four treatment groups: one received meclofenamate sodium 200 mg at dose 1 an...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/j.1875-9114.1986.tb03478.x

    authors: Hebertson RM,Storey N,Turner JL

    更新日期:1986-09-01 00:00:00

  • Symptomatic cardiotoxicity associated with 5-fluorouracil.

    abstract::A prospective cohort study was conducted in 35 hospitals with oncology units to determine the incidence of symptomatic cardiotoxicity in patients receiving continuous infusions of 5-fluorouracil (5-FU), and to identify risk factors that could contribute to the development of 5-FU-associated cardiotoxicity. A sample of...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Meyer CC,Calis KA,Burke LB,Walawander CA,Grasela TH

    更新日期:1997-07-01 00:00:00

  • Tacrolimus toxicity associated with concomitant metoclopramide therapy.

    abstract::Subtherapeutic tacrolimus trough concentrations were noted in a 52-year-old woman who had undergone liver transplantation. Her tacrolimus dosage was increased from 7 to 28 mg twice/day, and ketoconazole therapy was added; however, her tacrolimus concentration remained undetectable. Metoclopramide 10 mg 4 times/day was...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.5.532.33357

    authors: Prescott WA Jr,Callahan BL,Park JM

    更新日期:2004-04-01 00:00:00

  • Combination therapy with low-dose lovastatin and niacin is as effective as higher-dose lovastatin.

    abstract:STUDY OBJECTIVES:To determine if low-dose lovastatin in combination with niacin causes a greater percentage reduction in low-density lipoprotein (LDL) cholesterol than lovastatin alone, and to determine if the combination increases the risk of serious adverse effects. design. Prospective, randomized, open-label, clinic...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Gardner SF,Schneider EF,Granberry MC,Carter IR

    更新日期:1996-05-01 00:00:00

  • Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.

    abstract::Drug-induced thrombocytopenia is a rare but serious adverse event that has been associated with multiple drugs including β-lactams. Although it mostly occurs with prolonged medication use, some cases of rapid-onset thrombocytopenia have been reported. We describe the case of a 69-year-old man who developed severe and ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1675

    authors: Nguyen VD,Tourigny JF,Roy R,Brouillette D

    更新日期:2015-12-01 00:00:00

  • Paclitaxel (taxol).

    abstract::Paclitaxel is a novel antineoplastic that effects cytotoxicity by promoting intracellular tubulin polymerization and stabilizes abnormal microtubule structures against depolymerization. Although its clinical development had been hampered by misconceptions about its pharmacology, its scarcity, difficulties extracting i...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1994.tb02785.x

    authors: Kohler DR,Goldspiel BR

    更新日期:1994-01-01 00:00:00

  • Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy and safety of a new combination product, enalapril-diltiazem ER, when administered over the long term. DESIGN:Open-label, titration to response, with treatment lasting 46 weeks after a 6-week, double-blind phase. SETTING:Medical clinics in the private and academic sectors. PA...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Applegate W,Cohen JD,Wolfson P,Davis A,Green S

    更新日期:1997-01-01 00:00:00

  • ACCP Clinical Pharmacist Competencies.

    abstract::The purpose of the American College of Clinical Pharmacy (ACCP) is to advance human health by extending the frontiers of clinical pharmacy. Consistent with this mission and its core values, ACCP is committed to ensuring that clinical pharmacists possess the knowledge, skills, attitudes, and behaviors necessary to deli...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1923

    authors: Saseen JJ,Ripley TL,Bondi D,Burke JM,Cohen LJ,McBane S,McConnell KJ,Sackey B,Sanoski C,Simonyan A,Taylor J,Vande Griend JP

    更新日期:2017-05-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of fluoroquinolones.

    abstract::The pharmacokinetic characteristics of levofloxacin, moxifloxacin, and gatifloxacin include excellent oral bioavailability (90-99%), extensive penetration into tissues and body fluids, and an elimination half-life (6-12 hrs) that allows for once-daily dosing in patients with normal renal function. Levofloxacin and gat...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.16.233s.33992

    authors: Rodvold KA,Neuhauser M

    更新日期:2001-10-01 00:00:00

  • A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.

    abstract:STUDY OBJECTIVE:A safe alternative to erythropoiesis-stimulating agents to treat anemia is warranted in patients with cancer and anemia; thus the objective of this trial was to compare the efficacy and safety of intravenous (IV) iron isomaltoside with oral iron in patients with cancer and anemia by testing the noninfer...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1729

    authors: Birgegård G,Henry D,Glaspy J,Chopra R,Thomsen LL,Auerbach M

    更新日期:2016-04-01 00:00:00

  • Drug absorption in gastrointestinal disease and surgery.

    abstract::It is well recognized that drug absorption from the gastrointestinal tract is influenced by gastric and intestinal motility, surface area available for absorption, and physicochemical properties of the drug. Disease and surgery have been shown to alter these factors. Consequently, drug absorption can be altered as wel...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1989.tb04140.x

    authors: Gubbins PO,Bertch KE

    更新日期:1989-01-01 00:00:00

  • Pharmacists' assessment of dispensing errors: risk factors, practice sites, professional functions, and satisfaction.

    abstract::Certain demographic, practice, staffing, and pharmacist satisfaction variables may contribute to dispensing errors. A survey was randomly mailed to 7298 (50%) Texas pharmacists, of which 2862 were returned (39% response rate). Responders were 2437 pharmacists who indicated that they were in practice. Of these, 535 (23...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.21.6.614.34544

    authors: Bond CA,Raehl CL

    更新日期:2001-05-01 00:00:00

  • Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.

    abstract:STUDY OBJECTIVE:To determine if transitioning patients from a pharmacist- managed anticoagulation clinic after stabilization of warfarin therapy to physician-managed care alters the quality of anticoagulation care. DESIGN:Retrospective medical record review. SETTING:Pharmacist-managed, urban academic medical center-b...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.1.20

    authors: Garwood CL,Dumo P,Baringhaus SN,Laban KM

    更新日期:2008-01-01 00:00:00

  • Elevations in serum creatinine concentration: concerning or reassuring?

    abstract::The use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) has significantly reduced morbidity and mortality across the continuum of vascular disease. The utilization of these agents, however, remains suboptimal. The drugs are not prescribed in many patients because of concerns ...

    journal_title:Pharmacotherapy

    pub_type: 评论,杂志文章

    doi:10.1592/phco.24.6.697.34731

    authors: Epstein BJ

    更新日期:2004-05-01 00:00:00

  • Improving care transitions: current practice and future opportunities for pharmacists.

    abstract::During the past decade, patient safety issues during care transitions have gained greater attention at both the local and national level. Readmission rates to U.S. hospitals are high, often because of poor care transitions. Serious adverse drug events (ADEs) caused by an incomplete understanding of changes in complex ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1215

    authors: American College of Clinical Pharmacy.,Hume AL,Kirwin J,Bieber HL,Couchenour RL,Hall DL,Kennedy AK,LaPointe NM,Burkhardt CD,Schilli K,Seaton T,Trujillo J,Wiggins B

    更新日期:2012-11-01 00:00:00

  • Strategies to reduce toxicities and improve outcomes in renal transplant recipients.

    abstract::Ongoing improvements in immunosuppression and posttransplantation care have dramatically improved patient and graft outcomes after transplantation. The frequency of graft loss due to acute rejection has declined considerably as a result of the availability of a variety of more potent immunosuppressive agents and proba...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.5.316.33198

    authors: Lo A,Alloway RR

    更新日期:2002-03-01 00:00:00

  • Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.

    abstract::Few patients presenting with acute ischemic stroke (AIS) are eligible for alteplase, especially those receiving ongoing anticoagulation. We describe the first reported case of a patient receiving full-dose intravenous (IV) alteplase for AIS after heparin reversal with protamine. A 73-year-old man presented with AIS. H...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.1997

    authors: Fontaine GV,Smith SM

    更新日期:2017-10-01 00:00:00

  • Twice-daily Trizivir versus Combivir-abacavir in antiretroviral-experienced adults with human immunodeficiency virus-1 infection: a formulation-switch trial.

    abstract:STUDY OBJECTIVE:To establish the clinical equivalence (noninferiority) of one tablet containing abacavir 300 mg-lamivudine 150 mg-zidovudine 300 mg (Trizivir) versus a tablet containing lamivudine 150 mg-zidovudine 300 mg (Combivir) given with one abacavir (ABC) 300-mg tablet, administered twice/day, in antiretroviral-...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1592/phco.23.14.1432.31944

    authors: Fischl MA,Burnside AE Jr,Farthing CE,Thompson MA,Bellos NC,Williams VC,Kauf TL,Wannamaker PG,Shaefer MS,ESS40005 Study Team.

    更新日期:2003-11-01 00:00:00

  • Interpreting meta-analyses of pharmacologic interventions: the pitfalls and how to identify them.

    abstract::Meta-analyses are key components of evidence-based decision making. The numbers of meta-analyses published in different areas of health care increased dramatically during the past 10 years. Many of them covered different pharmacologic interventions, making them useful resources to clinical pharmacists. Although a well...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.9.741.31541

    authors: Etminan M,Levine M

    更新日期:1999-06-01 00:00:00

  • Alfuzosin treatment improves the rate and time for stone expulsion in patients with distal uretral stones: a prospective randomized controlled study.

    abstract:OBJECTIVE:To evaluate the safety and efficacy of alfuzosin treatment on rate and time of stone expulsion in patients with uncomplicated distal ureteral stones. PATIENTS AND METHODS:Prospective, randomized, open-label, controlled study. Patients > 18 years of age presenting to the outpatient urology clinic with uncompl...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/phar.1593

    authors: El Said NO,El Wakeel L,Kamal KM,Morad Ael R

    更新日期:2015-05-01 00:00:00

  • Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.

    abstract:STUDY OBJECTIVES:To evaluate the occurrence of bleeding and venous thromboembolic (VTE) events in patients receiving rivaroxaban, warfarin, or warfarin with the addition of enoxaparin during the immediate postoperative period following major orthopedic surgery. METHODS:Patients older than 18 years who received at leas...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1888

    authors: Cieri NE,Kusmierski K,Lackie C,Van Opdorp A,Hassan AK

    更新日期:2017-02-01 00:00:00

  • Pharmacotherapy for idiopathic pulmonary arterial hypertension during the past 25 years.

    abstract:OBJECTIVE:To review the current pharmacotherapy for idiopathic pulmonary arterial hypertension (IPAH). METHODS:A search of the primary literature was conducted by using MEDLINE, the National Institutes of Health medical research Web site (www.clinicaltrials.gov), and the United States Food and Drug Administration's Ce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2006.26.1.68

    authors: Hackman AM,Lackner TE

    更新日期:2006-01-01 00:00:00

  • Association of GGH Promoter Methylation Levels with Methotrexate Concentrations in Chinese Children with Acute Lymphoblastic Leukemia.

    abstract:BACKGROUND:It is known that γ-glutamyl hydrolase (GGH) is involved in the disposition of methotrexate (MTX), and GGH activity is regulated by DNA methylation in acute lymphoblastic leukemia (ALL) cells. The present study explores the methylation status of the GGH promoter in peripheral blood and its association with MT...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2430

    authors: Wang SM,Kong XY,Li M,Sun LL,Yan D

    更新日期:2020-07-01 00:00:00

  • Severe hypoglycemia from Helicobacter pylori triple-drug therapy and insulin detemir drug interaction.

    abstract::Two drugs commonly used in triple-drug therapy for treatment of a Helicobacter pylori infection, clarithromycin and omeprazole, have rarely been associated with hypoglycemia when given alone. No documented interactions between H. pylori treatment with clarithromycin, amoxicillin, and omeprazole and insulin detemir hav...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1228

    authors: Otsuka SH

    更新日期:2013-04-01 00:00:00

  • Dosage forms of cyclosporine.

    abstract::Cyclosporine can be given intravenously or orally, as a solution or soft gelatin capsule. Because of the drug's poor water solubility, ethoxylated plant fats and ethanol are added to the commercially available dosage forms. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Yee GC

    更新日期:1991-01-01 00:00:00

  • Epinephrine overdose-associated hypokalemia and rhabdomyolysis in a newborn.

    abstract::Epinephrine overdose induces many negative complications in adults because of its alpha- and beta-adrenoreceptor activity. However, complications in newborns or children are rarely described. A 4-day-old, 2004-g female newborn was inadvertently given epinephrine at 100 times the usual dose; she developed hypokalemia a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.2005.25.9.1266

    authors: Fang W,Chen JY,Fang Y,Huang JL

    更新日期:2005-09-01 00:00:00

  • The impact of hyponatremia.

    abstract::Hyponatremia is the most common electrolyte disorder encountered in clinical practice and is associated with significant morbidity and mortality. Clinical consequences of hyponatremia include neurologic dysfunction, decreased mental function, cerebral edema, gait disturbances and falls, osteoporosis, and fractures. Hy...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.5.5S

    authors: Patterson JH

    更新日期:2011-05-01 00:00:00

  • Acute ischemic stroke update.

    abstract::Stroke is the third most common cause of death in the United States and is the number one cause of long-term disability. Legislative mandates, largely the result of the American Heart Association, American Stroke Association, and Brain Attack Coalition working cooperatively, have resulted in nationwide standardization...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.30.5.493

    authors: Baldwin K,Orr S,Briand M,Piazza C,Veydt A,McCoy S

    更新日期:2010-05-01 00:00:00

  • Can the frequency and risks of fatal adverse drug events be determined?

    abstract::Death is the ultimate adverse drug event. Despite its importance, the frequency of fatal adverse drug events is unknown. Estimates in the United States are as high as 140,000/year, although this number is heavily disputed. Potential reasons and risks for fatal adverse drug events, as well as epidemiologic designs for ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.6.521.34540

    authors: Kelly WN

    更新日期:2001-05-01 00:00:00

  • Glucagon for Relief of Acute Esophageal Foreign Bodies and Food Impactions: A Systematic Review and Meta-Analysis.

    abstract::Glucagon is frequently used for the relief of esophageal impactions. This systematic review and meta-analysis were performed to evaluate the efficacy and safety of glucagon for acute esophageal foreign body and food impactions. PubMed, CINAHL, Latin American and Caribbean Health Sciences Literature (LILACS), Scopus, C...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,meta分析

    doi:10.1002/phar.2236

    authors: Peksa GD,DeMott JM,Slocum GW,Burkins J,Gottlieb M

    更新日期:2019-04-01 00:00:00